We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
George Han

George Han MD, PhD

Chair, Department of Dermatology, Mount Sinai Beth Israel, New York, New York

George Han, MD, PhD, currently serves as the System Medical Director for Dermatology at the Mount Sinai Health System. He is also the Chief of Teledermatology for the Department of Dermatology at the Icahn School of Medicine at Mount Sinai. Dr. Han is the current Vice President of the Dermatologic Society of Greater New York and a member of the Medical Board of the National Psoriasis Foundation. To date, he has two patents and over 40 publications in well-respected journals such as the Journal of the American Academy of Dermatology, the Journal of Investigative Dermatology, the Journal of Infectious Diseases, and the American Journal of Pathology. Dr. Han remains active in both basic science research and clinical trials, serving as Principal Investigator in numerous clinical trials encompassing clinical area such as Psoriasis, Atopic Dermatitis, Vitiligo, and Actinic Keratosis and conducting translational research on the role of neutrophils in psoriasis.

Disclosures

Dr. Han is or has been an investigator, consultant/advisor, or speaker for Abbvie, Athenex, Boehringer Ingelheim, Bond Avillion, Bristol-Myers Squibb, Celgene, Eli Lilly, Novartis, Janssen, LEO Pharma, MC2, Ortho Dermatologics, PellePharm, Pfizer, Regeneron, Sanofi Genzyme, SUN Pharmaceuticals and UCB.